Tommy Andersson
6 – 10 of 67
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells
(
- Contribution to journal › Article
-
Mark
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
(
- Contribution to journal › Article
- 2018
-
Mark
WNT5A as a therapeutic target in breast cancer
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Optimization, validation, and identification of two reliable antibodies for immunodetection of WNT5A
(
- Contribution to journal › Article
-
Mark
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
(
- Contribution to journal › Article